2022
DOI: 10.1038/s41565-022-01085-5
|View full text |Cite|
|
Sign up to set email alerts
|

A transistor-like pH-sensitive nanodetergent for selective cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
70
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(71 citation statements)
references
References 35 publications
0
70
0
1
Order By: Relevance
“…This phenomenon could be the result of pore formation in cell membrane after the antibacterial combination treatment and a subsequent release of intracellular substances. [ 57‐58 ]…”
Section: Resultsmentioning
confidence: 99%
“…This phenomenon could be the result of pore formation in cell membrane after the antibacterial combination treatment and a subsequent release of intracellular substances. [ 57‐58 ]…”
Section: Resultsmentioning
confidence: 99%
“…193 The differences in extracellular and intracellular pH between cancer and healthy cells can be used to develop pH-sensitive polymer nanomaterials to rupture the plasma membrane of cancer cells. 194 Liu et al developed polymer nanomaterials that exhibited potent membranolytic activity and could selectively destroy the plasma membrane of cancer cells while these pH-sensitive polymer nanomaterials showed low toxicity to healthy cells. 194…”
Section: Extracellular and Intracellular Phmentioning
confidence: 99%
“…194 Liu et al developed polymer nanomaterials that exhibited potent membranolytic activity and could selectively destroy the plasma membrane of cancer cells while these pH-sensitive polymer nanomaterials showed low toxicity to healthy cells. 194…”
Section: Extracellular and Intracellular Phmentioning
confidence: 99%
“…Targeting the tumor involves the use of ligands specific to tumor cells or tumor microenvironments. Many of the common targeting ligands have sensitivity to pH 27 , enzyme reactivity 25 , temperature 28 , and other biomarkers.…”
Section: Tumor Targeting and Extravasationmentioning
confidence: 99%